Advaita Bioinformatics Awarded $1.8M for Disease Subtype ID Tech | GenomeWeb

NEW YORK (GenomeWeb) – Advaita Bioinformatics has received a notice of award from the National Institute of General Medical Sciences for a Phase II Small Business Investigational Research grant to develop and implement a new method of identifying disease subtypes and subgroups of patients within disease phenotypes.

The Plymouth, Mich.-based firm will use the three-year, $1.8 million grant also to identify biological pathway signatures for specific diseases and to identify pathway signatures for drugs in order to repurpose them, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.

Feb
25
Sponsored by
Omicia

This webinar will demonstrate how ACMG's recommended variant scoring and classification rules may be applied to standardize reporting on sequencing test results within and across institutions.